Ischaemic heart disease Circulatory System Ischaemic heart disease
Conditions
Interventions
Patients will be randomised to:
1. 5 mmol/l Magnesium (Mg2+)
2. 16 mmol/l Mg2+)
In the intermittent antegrade warm blood cardioplegia
Sponsors
British Heart Foundation (UK)
Eligibility
Inclusion criteria
Inclusion criteria: 1. A diagnosis of ischaemic heart disease 2. Undergoing primary myocardial revascularisation with the use of cardiopulmonary bypass and cardioplegic arrest
Exclusion criteria
Exclusion criteria: Not provided at time of registration
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Not provided at time of registration | — |
Secondary
| Measure | Time frame |
|---|---|
| Not provided at time of registration | — |
Countries
United Kingdom
Outcome results
None listed